Patent ID: 8450525
Filing Date: 2013-05-28
Classification: A61P,C07C,C07D

Abstract:
1. A compound of formula (I): their tautomeric form, stereoisomer, pharmaceutically acceptable salt, or pharmaceutical composition thereof; wherein, the configuration around the double bonds may be E/Z; R represents substituted or unsubstituted groups selected from aryl, cycloalkyl, heteroaryl, arylalkyl, heterocyclyl and heteroarylalkyl; R R R R X represents —O—, —NR Y represents aryl and arylalkenyl; m is an integer from 0-3; n is an integer from 0-1; o is an integer from 0-7 and p is an integer from 0-1, when the groups R, R the substituents which in turn are further optionally substituted by halogens comprising fluorine, chlorine, bromine or iodine; hydroxy, nitro, cycloalkyl, cyano, azido, nitroso, amino, hydrazino, formyl, alkyl, or haloalkyl group comprising trifluoromethyl or tribromoethyl; with the proviso that, if n, o and p=0, then m=0-1; and with the proviso that, if n=1, o=3-7 and p=0, then m=0-1; and with the proviso that, if n, o and p=1, then m=0-1.